Does Teaching Before or After Simulation Improve Learning?

Sponsor
University of British Columbia (Other)
Overall Status
Recruiting
CT.gov ID
NCT06092320
Collaborator
(none)
40
1
2
8.4
4.8

Study Details

Study Description

Brief Summary

The goal of the randomized educational intervention study is to test whether simulation preceding didactic teaching leads to improved knowledge and performance retention compared to a didactic lecture proceeding simulation for medical students

Participants will be randomized to one of two different groups with reverse orders for simulation and lectures.

Researchers will compare each group to see which way is better for learning.

Condition or Disease Intervention/Treatment Phase
  • Other: Simulation on Pediatric Status Epilepticus
  • Other: Didactic Lecture on Pediatric Status Epilepticus
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Participants will not know the specific pediatric resuscitation simulation they will be completing. Simulation reviewers will not know which arm of the intervention the participants are in.
Primary Purpose:
Other
Official Title:
Outcome of a Lecture Before vs After Simulation-based Education on Pediatric Status Epileptics: A Randomized Controlled Pilot Trial
Actual Study Start Date :
Sep 20, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Simulation - Didactic Lecture Group

This group will start with a Simulation and debrief followed by a didactic lecture afterwards. They will then complete a simulation 2 months later.

Other: Simulation on Pediatric Status Epilepticus
The participants will complete a simulation session and debrief lead by a pediatric emergency medicine physician on status epilepticus.

Other: Didactic Lecture on Pediatric Status Epilepticus
The participants will complete a lecture on pediatric status epilepticus

Experimental: Didactic Lecture - Simulation Group

This group will start with a didactic lecture and then complete a simulation and debrief. They will then complete a simulation 2 months later.

Other: Simulation on Pediatric Status Epilepticus
The participants will complete a simulation session and debrief lead by a pediatric emergency medicine physician on status epilepticus.

Other: Didactic Lecture on Pediatric Status Epilepticus
The participants will complete a lecture on pediatric status epilepticus

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in resuscitation performance retention score 2 months post-initial training assessed using global simulation performance score [From initial simulation until repeat simulation 2 months later]

    The scoring sheet used will be the Global Simulation performance score a one to seven scale that assess over medical expertise performance in the simulation with higher values representing increased competence.

Secondary Outcome Measures

  1. Change in knowledge assessment score at 2 months post-initial training assessed using an MCQ [From initial knowledge test until repeat testing 2 months later]

    The knowledge test is a 15 questions multiple choice exam scored from 0 to 15 with higher numbers representing a higher score.

  2. Learner satisfaction measured by Likert scale items after each simulation debrief [Single time metric completed five minutes after initial simulation session]

    The Likert scale will be a one to five scale with higher scores representing increased satisfaction

  3. Time to resuscitation metrics [The time for each metric will be measured once during the second evaluatory simulation 2 months after the initial simulation and participant enrolment.]

    The following "time to" metrics will be measured from simulation start until completion of each activity within that simulation: glucose check, IV access, first-line anti-epileptic administration, second-line anti-epileptic administration, chemistry panel

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Second year medical student at the University of British Columbia
Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 BC Children's Hospital Vancouver British Columbia Canada V6H 3N1

Sponsors and Collaborators

  • University of British Columbia

Investigators

  • Principal Investigator: Melissa Chan, MD, Provincial Health Services Authority

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Melissa Chan, Principle Investigator, University of British Columbia
ClinicalTrials.gov Identifier:
NCT06092320
Other Study ID Numbers:
  • H22-03760
First Posted:
Oct 23, 2023
Last Update Posted:
Oct 23, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Melissa Chan, Principle Investigator, University of British Columbia

Study Results

No Results Posted as of Oct 23, 2023